DGX
Quest Diagnostics Incorporated
Stock
$233.33+2.24 (+0.97%)Close Oct 2, 2026
Income statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.6B | $11.0B | $9.9B | $9.3B | $9.9B | $10.8B | $9.4B | $7.7B | $7.5B | $7.4B | $7.2B | $7.5B | $7.4B | $7.1B | $7.4B | $7.4B | $7.3B | $7.5B | $7.2B | $6.7B |
| Cost of revenue | — | — | — | — | — | — | $5.8B | $5.0B | $4.9B | $4.7B | $4.3B | $4.7B | $4.6B | $4.3B | $4.4B | $4.4B | $4.2B | $4.3B | — | — |
| Gross profit | — | — | — | — | — | — | $3.6B | $2.7B | $2.6B | $2.7B | $2.9B | $2.8B | $2.8B | $2.8B | $3.0B | $3.0B | $3.1B | $3.1B | — | — |
| SG&A | $2.0B | $2.0B | $1.8B | $1.6B | $1.9B | $1.7B | $1.6B | $1.5B | $1.4B | $1.4B | $1.4B | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B | $1.6B |
| Other operating expenses | — | — | — | — | — | — | $112M | — | $80M | $75M | $242M | — | $87M | — | $72M | $299M | $109M | $27M | — | — |
| Operating income | $1.6B | $1.6B | $1.3B | $1.3B | $1.4B | $2.4B | $2.0B | $1.2B | $1.1B | $1.2B | $1.3B | $1.4B | $983M | $1.5B | $1.2B | $987M | $1.3B | $1.4B | $1.2B | $1.1B |
| Non-operating income | −$226M | −$238M | −$171M | −$132M | −$193M | $218M | −$87M | −$155M | −$175M | −$135M | −$191M | −$296M | −$160M | −$151M | — | −$131M | −$99M | −$131M | −$172M | — |
| Pretax income | $1.4B | $1.3B | $1.2B | $1.1B | $1.2B | $2.6B | $1.9B | $1.1B | $926M | $1.0B | $1.1B | $1.1B | $823M | $1.3B | — | $856M | $1.2B | $1.2B | $1.1B | — |
| Taxes | $342M | $326M | $304M | $276M | $289M | $604M | $453M | $218M | $190M | $258M | $441M | $394M | $267M | $475M | — | $385M | $463M | $499M | $469M | — |
| Net income | $1.1B | $992M | $871M | $854M | $946M | $2.0B | $1.4B | $858M | $736M | $772M | $645M | $709M | $556M | $849M | $556M | $471M | $721M | $729M | $581M | $340M |
| Diluted EPS | $9.41 | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 | $10.47 | $6.28 | $5.29 | $5.50 | $4.51 | $4.87 | $3.81 | $5.54 | $3.46 | $2.92 | $4.05 | $3.87 | $2.96 | $1.74 |
| Diluted shares | — | 113.0M | 113.0M | 113.0M | 118.0M | 128.0M | 136.0M | 136.0M | 139.0M | 140.0M | 142.0M | 145.0M | 145.0M | 153.0M | 160.0M | 160.0M | 177.3M | 187.8M | 196.0M | — |
| Revenue growth | — | +11.8% | +6.7% | −6.4% | −8.4% | +14.3% | +22.1% | +2.6% | +1.7% | +2.6% | −3.7% | +0.8% | +4.0% | −3.2% | −0.1% | +1.8% | −2.6% | +2.8% | +8.1% | — |
| Gross margin | — | — | — | — | — | — | 38.5% | 34.8% | 34.6% | 36.2% | 40.2% | 37.8% | 37.6% | 39.5% | 40.9% | 41.0% | 42.0% | 42.0% | — | — |
| Operating margin | 14.1% | 14.1% | 13.6% | 13.6% | 14.4% | 22.1% | 20.9% | 15.9% | 14.6% | 15.7% | 17.7% | 18.7% | 13.2% | 20.6% | 16.3% | 13.4% | 17.7% | 18.2% | 16.9% | 16.3% |
| Net margin | 9.2% | 9.0% | 8.8% | 9.2% | 9.6% | 18.5% | 15.2% | 11.1% | 9.8% | 10.4% | 8.9% | 9.5% | 7.5% | 11.9% | 7.5% | 6.4% | 9.9% | 9.8% | 8.0% | 5.1% |